Vulvar Cancer | Tumor

CURE’s vulvar cancer page features the latest cancer news and updates on vulvar cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in vulvar cancer.

Get Schooled on Vulvar Cancer

April 10th 2020

A patient turned advocate underscores the importance of education, especially for those facing a rare cancer.

New Issue Alert: CURE Women's Cancers

April 4th 2019

We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.

Patients With Gynecologic Cancers Want to Discuss Sexual Health

January 25th 2019

Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.

FDA Approves Age Expansion of HPV Vaccine

October 6th 2018

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

FDA Grants Priority Review to GARDASIL 9 for Expanded Age Indication

June 13th 2018

The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.

HPV Status Linked to Overall and Disease-Free Survival in Vulvar Cancer

March 21st 2018

Women with vulvar cancer who test positive for human papillomavirus (HPV) may have improved survival compared with HPV-negative patients, according to the results of a new study.

Despite Benefits, HPV Vaccination Rates Remain Too Low

May 18th 2017

Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.

NCCN Introduces Updated Vulvar Cancer Guideline

April 27th 2017

Treatment changes for the rare illness include less invasive surgery.

HPV Vaccination in Boys Found Cost-Effective in Preventing Oropharyngeal Cancer

April 17th 2015

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.

Study Highlights Geographical Differences in Cervical Cancer Incidence

February 20th 2015

States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.

The Thing About Risk

January 23rd 2015

There are some things known to increase the risk of gynecologic cancers. Bottom line, being a woman puts you at risk.

NORD Offers Information and Support for Patients of Rare Cancers

November 25th 2014

NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.

Meetings of the Minds

September 15th 2009

What is multidisciplinary care, and where can patients get it?